432 related articles for article (PubMed ID: 34014158)
1. Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis.
Monti S; Felicetti M; Delvino P; Padoan R; Berti A; Paolazzi G; Brunori G; Schiavon F; Caporali R; Montecucco C
Clin Exp Rheumatol; 2021; 39 Suppl 129(2):107-113. PubMed ID: 34014158
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China.
Chang DY; Li ZY; Chen M; Zhao MH
Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan.
Ono N; Niiro H; Ueda A; Sawabe T; Nishizaka H; Furugo I; Yoshizawa S; Yoshizawa S; Tsukamoto H; Kiyohara C; Tada Y; Horiuchi T
Rheumatol Int; 2015 Mar; 35(3):555-9. PubMed ID: 25129031
[TBL] [Abstract][Full Text] [Related]
5. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
[TBL] [Abstract][Full Text] [Related]
7. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A
Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643
[TBL] [Abstract][Full Text] [Related]
9. Childhood-Onset ANCA- Associated Vasculitis: single center experience from Central California.
Singh D; Sukumaran S
Pediatr Rheumatol Online J; 2023 Jul; 21(1):66. PubMed ID: 37400890
[TBL] [Abstract][Full Text] [Related]
10. Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis.
Walker BS; Peterson LK; Koening C; White SK; Schmidt RL; Tebo AE
Autoimmun Rev; 2022 Jun; 21(6):103100. PubMed ID: 35452854
[TBL] [Abstract][Full Text] [Related]
11. Relevance of Combined Clinicopathologic Phenotype and Antineutrophil Cytoplasmic Autoantibody Serotype in the Diagnosis of Antineutrophil Cytoplasmic Autoantibody Vasculitis.
Alba MA; Jennette JC; Hu Y; Poulton CJ; Blazek L; Derebail VK; Falk RJ; Hogan SL
Kidney Int Rep; 2022 Dec; 7(12):2676-2690. PubMed ID: 36506241
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
13. Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.
Wójcik K; Masiak A; Jeleniewicz R; Jakuszko K; Brzosko I; Storoniak H; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz EJ;
Pol Arch Intern Med; 2022 Mar; 132(3):. PubMed ID: 34985235
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
Kim SM; Choi SY; Kim SY; Kim J
Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group Registry.
Puéchal X; Iudici M; Pagnoux C; Cohen P; Hamidou M; Aouba A; Lifermann F; Ruivard M; Aumaître O; Bonnotte B; Maurier F; Le Gallou T; Hachulla E; Karras A; Khouatra C; Jourde-Chiche N; Viallard JF; Blanchard-Delaunay C; Godmer P; Le Quellec A; Quéméneur T; de Moreuil C; Mouthon L; Terrier B; Guillevin L;
RMD Open; 2022 Mar; 8(1):. PubMed ID: 35296533
[TBL] [Abstract][Full Text] [Related]
16. Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
Yoshida Y; Nakamoto N; Oka N; Kidoguchi G; Hosokawa Y; Araki K; Ishitoku M; Watanabe H; Sugimoto T; Mokuda S; Kida T; Yajima N; Omura S; Nakagomi D; Abe Y; Kadoya M; Takizawa N; Nomura A; Kukida Y; Kondo N; Yamano Y; Yanagida T; Endo K; Matsui K; Takeuchi T; Ichinose K; Kato M; Yanai R; Matsuo Y; Shimojima Y; Nishioka R; Okazaki R; Takata T; Ito T; Moriyama M; Takatani A; Miyawaki Y; Ito-Ihara T; Kawaguchi T; Kawahito Y; Hirata S
J Rheumatol; 2023 Sep; 50(9):1152-1158. PubMed ID: 37263656
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of interleukin-32 and interleukin-6 in granulomatosis with polyangiitis and microscopic polyangiitis: association with clinical and biochemical findings.
Krajewska Wojciechowska J; Kościelska-Kasprzak K; Krajewski W; Morawski K
Eur Cytokine Netw; 2019 Dec; 30(4):151-159. PubMed ID: 32096477
[TBL] [Abstract][Full Text] [Related]
18. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.
Trivioli G; Marquez A; Martorana D; Tesi M; Kronbichler A; Lyons PA; Vaglio A
Nat Rev Rheumatol; 2022 Oct; 18(10):559-574. PubMed ID: 36109667
[TBL] [Abstract][Full Text] [Related]
19. ANCA associated vasculitis (AAV): a review for internists.
Yaseen K; Mandell BF
Postgrad Med; 2023 Jan; 135(sup1):3-13. PubMed ID: 35831990
[TBL] [Abstract][Full Text] [Related]
20. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.
Lionaki S; Blyth ER; Hogan SL; Hu Y; Senior BA; Jennette CE; Nachman PH; Jennette JC; Falk RJ
Arthritis Rheum; 2012 Oct; 64(10):3452-62. PubMed ID: 23023777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
